Original Research
Published on 30 Apr 2024
MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon
in Cancer Molecular Targets and Therapeutics
- 297 views
Original Research
Published on 30 Apr 2024
in Cancer Molecular Targets and Therapeutics
Brief Research Report
Accepted on 29 Apr 2024
in Cancer Molecular Targets and Therapeutics
Review
Published on 25 Apr 2024
in Cancer Molecular Targets and Therapeutics
Mini Review
Accepted on 24 Apr 2024
in Cancer Molecular Targets and Therapeutics
Mini Review
Accepted on 22 Apr 2024
in Cancer Molecular Targets and Therapeutics
Editorial
Published on 19 Apr 2024
in Cancer Molecular Targets and Therapeutics
Clinical Trial
Published on 19 Apr 2024
in Cancer Molecular Targets and Therapeutics
Review
Published on 18 Apr 2024
in Cancer Molecular Targets and Therapeutics
Brief Research Report
Published on 18 Apr 2024
in Cancer Molecular Targets and Therapeutics
Perspective
Accepted on 15 Apr 2024
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 08 Apr 2024
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 04 Apr 2024
in Cancer Molecular Targets and Therapeutics
Review
Published on 28 Mar 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 25 Mar 2024
in Cancer Molecular Targets and Therapeutics
Retraction
Published on 20 Mar 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 14 Mar 2024
in Cancer Molecular Targets and Therapeutics